X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13238) 13238
Publication (491) 491
Book Review (467) 467
Newsletter (69) 69
Book Chapter (17) 17
Conference Proceeding (8) 8
Book / eBook (1) 1
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12509) 12509
animals (8502) 8502
humans (5234) 5234
tetradecanoylphorbol acetate - pharmacology (4930) 4930
phorbol ester (4056) 4056
protein kinase c - metabolism (3773) 3773
phorbol esters - pharmacology (3554) 3554
phorbol esters (3449) 3449
rats (3337) 3337
biochemistry & molecular biology (3091) 3091
cells, cultured (2648) 2648
mice (2568) 2568
phosphorylation (2469) 2469
protein kinase c (2469) 2469
male (2180) 2180
cell line (2004) 2004
protein-kinase-c (1861) 1861
cell biology (1774) 1774
kinetics (1717) 1717
activation (1695) 1695
protein kinase c - antagonists & inhibitors (1655) 1655
pharmacology & pharmacy (1503) 1503
female (1481) 1481
in vitro techniques (1455) 1455
calcium - metabolism (1326) 1326
signal transduction (1319) 1319
enzyme activation (1302) 1302
phorbol 12,13-dibutyrate - pharmacology (1271) 1271
expression (1190) 1190
dose-response relationship, drug (1186) 1186
cells (1135) 1135
enzyme inhibitors - pharmacology (1097) 1097
tumor cells, cultured (1097) 1097
phorbols - pharmacology (1083) 1083
neurosciences (1080) 1080
enzyme activation - drug effects (1039) 1039
protein kinase c - physiology (1031) 1031
time factors (929) 929
calcium (902) 902
physiology (860) 860
oncology (813) 813
molecular sequence data (781) 781
isoenzymes - metabolism (771) 771
protein kinase-c (735) 735
abridged index medicus (720) 720
biophysics (689) 689
rats, sprague-dawley (678) 678
immunology (660) 660
cell division - drug effects (654) 654
proteins (648) 648
endocrinology & metabolism (633) 633
protein kinases (627) 627
carcinogens - pharmacology (624) 624
down-regulation (615) 615
inhibition (612) 612
staurosporine (610) 610
cell differentiation - drug effects (604) 604
rna, messenger - metabolism (588) 588
transfection (577) 577
signal transduction - drug effects (570) 570
gene-expression (561) 561
diglycerides - pharmacology (560) 560
rats, inbred strains (543) 543
calcium - pharmacology (531) 531
alkaloids - pharmacology (526) 526
colforsin - pharmacology (526) 526
calcimycin - pharmacology (523) 523
blotting, western (511) 511
differentiation (509) 509
phorbol 12,13-dibutyrate (509) 509
amino acid sequence (502) 502
research (482) 482
messenger-rna (479) 479
base sequence (476) 476
cattle (463) 463
cyclic amp - metabolism (460) 460
receptor (457) 457
receptors (445) 445
indoles - pharmacology (439) 439
rats, wistar (434) 434
carcinogens (418) 418
binding (408) 408
stimulation (408) 408
rna, messenger - genetics (406) 406
signal-transduction (406) 406
gene expression (396) 396
rabbits (395) 395
diacylglycerol (394) 394
isoquinolines - pharmacology (393) 393
cell membrane - metabolism (390) 390
physiological aspects (383) 383
esters (380) 380
drug synergism (378) 378
gene expression regulation - drug effects (378) 378
analysis (370) 370
induction (369) 369
apoptosis (365) 365
protein kinases - metabolism (354) 354
growth-factor (350) 350
piperazines - pharmacology (349) 349
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13206) 13206
Japanese (47) 47
Russian (27) 27
Chinese (23) 23
French (6) 6
German (2) 2
Polish (2) 2
Spanish (2) 2
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 05/2015, Volume 125, Issue 5, pp. 1901 - 1912
Reversal of HIV-1 latency by small molecules is a potential cure strategy. This approach will likely require effective drug combinations to achieve high levels... 
SUPPRESSIVE ANTIRETROVIRAL THERAPY | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS REACTIVATION | ACTIVATION | RESERVOIR | IN-VIVO | GENE-EXPRESSION | CD4(+) T-CELLS | HISTONE DEACETYLASE INHIBITORS | NF-KAPPA-B | LIFELONG PERSISTENCE | Anti-HIV Agents - pharmacology | Transcription, Genetic - drug effects | Lymphokines - secretion | Humans | Middle Aged | RNA, Messenger - analysis | Male | Virus Latency - drug effects | Anti-HIV Agents - administration & dosage | HIV-1 - physiology | Phorbol Esters - pharmacology | Adult | Anti-HIV Agents - therapeutic use | Female | CD4-Positive T-Lymphocytes - virology | Drug Evaluation, Preclinical | Bryostatins - pharmacology | HIV-1 - drug effects | Lymphocyte Activation | HIV Infections - virology | Protein Kinase C - drug effects | Cells, Cultured | RNA, Viral - analysis | Virion - metabolism | Azepines - pharmacology | Drug Synergism | Triazoles - pharmacology | CD4-Positive T-Lymphocytes - secretion | HIV Infections - drug therapy | Histone Deacetylase Inhibitors - pharmacology | Disulfiram - pharmacology | CD4-Positive T-Lymphocytes - drug effects | Physiological aspects | Research | RNA | T cells | Drug therapy | HIV infection | Studies | Statistical analysis | Cytokines | Acquired immune deficiency syndrome--AIDS | Lymphocytes | T cell receptors | Mathematical models | Gene expression | Index Medicus | Abridged Index Medicus | HIV | Infectious disease | AIDS
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2009, Volume 4, Issue 6, pp. e6093 - e6093
The persistence of transcriptionally silent but replication-competent HIV-1 reservoirs in Highly Active Anti-Retroviral Therapy (HAART)-treated infected... 
MULTIDISCIPLINARY SCIENCES | Anti-HIV Agents - pharmacology | HIV-1 - metabolism | NF-KappaB Inhibitor alpha | NF-kappa B - antagonists & inhibitors | Humans | Middle Aged | Enzyme Inhibitors - pharmacology | Nucleosomes - metabolism | Cytoplasm - metabolism | I-kappa B Proteins - metabolism | Virus Latency - drug effects | Drug Synergism | Monocytes - virology | Cell Nucleus - metabolism | CD8-Positive T-Lymphocytes - metabolism | Phorbol Esters - pharmacology | Adult | HIV Infections - drug therapy | HIV-1 - enzymology | Aged | Highly active antiretroviral therapy | Antiviral agents | Control | Physiological aspects | Genetic research | Genetic transcription | T cells | HIV (Viruses) | Health aspects | Therapy | Oxidative stress | Histone deacetylase | Transcription | Laboratories | CD8 antigen | Leukocytes (mononuclear) | Viruses | Lymphocytes T | Infections | Activation | Remodeling | DNA-directed RNA polymerase | Synergism | Recruitment | Long terminal repeat | Cell growth | Transfection | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Peripheral blood mononuclear cells | Elongation | Deoxyribonucleic acid--DNA | NF-κB protein | Latent infection | Gene expression | Patients | Virology | CD4 antigen | Polymerase | Monocytes | Inhibitors | Ribonucleic acids | Replication | Reservoirs | Combined treatment | RNA polymerase II | Index Medicus | HIV Infections | HIV-1 | Enzyme Inhibitors | Virus Latency | I-kappa B Proteins | Anti-HIV Agents | CD8-Positive T-Lymphocytes | Life Sciences | Microbiology and Parasitology | NF-kappa B | Nucleosomes | Phorbol Esters | Cell Nucleus | Cytoplasm | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | DNA | Human immunodeficiency virus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2013, Volume 110, Issue 29, pp. 11698 - 11703
Highly active antiretroviral therapy (HAART) decreases plasma viremia below the limits of detection in the majority of HIV-infected individuals, thus serving... 
T lymphocytes | Highly active antiretroviral therapy | HIV | Cell lines | Lead | Viruses | Cell surface receptors | Phorbols | Acetates | HIV 1 | NF-?B | HIV latency | PKC-d | Bryostatin | PROTEIN-KINASE-C | ACTIVATION | PKC-delta | MULTIDISCIPLINARY SCIENCES | HOMALANTHUS-NUTANS | RESERVOIRS | NF-kappa B | 12-DEOXYPHORBOL | ACTIVE ANTIRETROVIRAL THERAPY | bryostatin | ERADICATION | PROVIDES | PHORBOL ESTER | HAART | Gene Expression Regulation, Viral - drug effects | Virus Activation - physiology | Magnetic Resonance Spectroscopy | Humans | Phorbol Esters - therapeutic use | Antigens, Differentiation, T-Lymphocyte - metabolism | Phorbol Esters - chemistry | Antigens, CD - metabolism | Phorbol Esters - chemical synthesis | Lectins, C-Type - metabolism | Flow Cytometry | Virus Activation - drug effects | Protein Kinase C - metabolism | Phorbol Esters - pharmacology | Protein Binding | HIV Infections - drug therapy | Molecular Structure | Antiretroviral Therapy, Highly Active - methods | CD4-Positive T-Lymphocytes - virology | Usage | Viremia | Physiological aspects | Genetic aspects | Properties | Drug therapy | T cells | HIV infection | Protein kinases | Lactones | Antiretroviral drugs | T cell receptors | Human immunodeficiency virus--HIV | Medical treatment | Index Medicus | Biological Sciences | NF-κB | Physical Sciences | PKC-δ
Journal Article
Cell, ISSN 0092-8674, 2005, Volume 123, Issue 4, pp. 569 - 580
Journal Article